B-039 Harmonizing M-protein analysis: an international, multi-center reproducibility study of the EXENT® System and evaluation of concordance to electrophoretic methods
Abstract
Standard methods for M-protein analysis include serum protein electrophoresis (SPE), capillary zone electrophoresis (CZE), immunofixation electrophoresis (IFE) and immunotyping (IT). These assays are cornerstones for diagnosis and monitoring of monoclonal gammopathies. The EXENT® System combines the EXENT Analyser with the EXENT GAM Assay to provide a fully automated mass spectrometry (MS) solution for monoclonal protein assessment and may offer advantages over standard methods. As adoption of the EXENT System expands, evaluation of inter-site reproducibility and assay standardization is critical, particularly in multi-center clinical settings. This study assessed the reproducibility of the EXENT System across five international clinical laboratories, with a specific focus on the EXENT System concordance between sites and a comparison to conventional methods. Serum samples that were banked at Binding Site were used for the study. Seventeen samples with a confirmed monoclonal protein (4 IgG, 8 IgA, 5 IgM) were collected and serially diluted in normal human serum, along with a negative control totaling 120 specimens. Five university hospital laboratories received the sample cohort and were blinded to sample information. Samples were analyzed using their standard SPE/CZE and IFE/IT workflows, as well as the EXENT System. Total immunoglobulins (IgG, IgA, and IgM) were measured using Optilite® assays, and monoclonal protein concentrations were determined using the EXENT System. Inter-site concordance was evaluated using Passing–Bablok regression and Spearman’s rank correlation (rs). Mass precision, MS isotype and concordance to IFE/IT were analyzed. Analytical variability was assessed using coefficient of variation (CV%). Passing-Bablok regression identified a median slope of 1.004 for SPE/CZE and MS. Inter-site mass precision by MS revealed >99% of samples =4 m/z difference from the expected value. Isotype concordance by MS showed agreements for 100%, 97% and 95% of IgG, IgA and IgM samples, respectively. MS concordance to IFE/IT was 81.5%, with most discordances attributed to IFE/IT biclonal/MS monoclonal or IFE/IT negative/MS positive samples. Across the ten unique inter-site pairs, MS displayed robust M-protein measurements and improved concordance compared to inter-site SPE/CZE analysis, with slopes close to unity and high correlation coefficients by Spearman’s rs (see supporting table). Although strong proportional agreements were observed for MS, inter-site CV% for M-protein analysis revealed slight variabilities, albeit not as significant as SPE/CZE (32% of samples by MS versus 53% of samples by SPE/CZE were >15% CV), with MS median CV% in this cohort being 21.2%. Elevated CV% values for MS were more pronounced for concentrated samples or IgM monoclonal proteins. Elevated CV% may be a result of multi-factorial influences, including inherent analytical variation in Optilite measurements, complexities in mass spectrometry modeling and pre-analytical variables related to sample stability, inter-laboratory sample handling and international shipping logistics. This multi-center evaluation demonstrates that the EXENT System exhibits strong relative reproducibility across independent sites globally, as evidenced by high correlation and consistent proportional agreement. Additionally, the EXENT System demonstrated improved consistency compared to traditional electrophoretic methods. These findings suggest that the EXENT System is a robust platform capable of generating analogous data across clinical laboratories.